Intrinsic Value of S&P & Nasdaq Contact Us

Anteris Technologies Ltd AMEUF OTC

Other OTC • Healthcare • Medical - Devices • AU • USD

SharesGrow Score
24/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Anteris Technologies Ltd (AMEUF) .

Criteria proven by this page:

  • VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 23/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
24/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
N/A
No coverage
PAST
0/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
MOAT
28/100
→ Income
GROWTH
15/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — AMEUF

Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio26.43
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-6.09
Book Value / Share$0.00
Revenue / Share$0.22
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2015 $-16.48 $10.13M $-25.25M -249.2%
2016 $-12.58 $14.15M $-24.01M -169.7%
2017 $-4.90 $22.32M $-12.31M -55.2%
2018 $-7.93 $25.6M $-24.22M -94.6%
2019 $-0.99 $17.08M $-5.82M -34.1%
2020 $-2.58 $7.08M $-15.27M -215.8%
2021 $-3.09 $7.79M $-22.91M -294%
2022 $-3.32 $4.59M $-44.34M -966%
2023 $-4.31 $4.11M $-67.33M -1637.9%
2024 $-6.09 $4.37M $-123.26M -2822.5%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message